Original Research

Assessment of Cognitive Functioning in Diabetic Patients with Diabetic Foot

DOI https://doi.org/10.70302/jpsim.v5i4.2472
Received: 20 Feb 2024 Accepted: 31 Oct 2024 Published Online: 09 Dec 2024

Abstract

Objective

To determine the prevalence of poor cognitive functioning in diabetics with diabetic foot.

Methods

This cross sectional study was undertaken at Combined Military Hospital (CMH) Rawalpindi, from September
to December 2021. The study included 190 patients, known to be diabetic, aged 40 to 70 years of either gender, with
diabetic foot, presenting to Department of medicine CMH Rwp. Patients with advanced kidney disease and dementia were
excluded. Informed consent was taken from all patients. Mini-Mental State investigation (MMSE) results were used to
evaluate overall mental condition (Folstein, Folstein, & McHugh, 1975). Score was noted and if MMSE score was found
24, poor cognitive function was labeled

Results

The mean age of the patients was 60±7.84 years. In our study, 132(69.47%) were males and 58(30.53%) were
females. The mean duration of disease of the patients was 11.66±4.58 years. 22(11.70%) patients were on oral treatment,
72(38.30%) were on insulin and 94(50%) patients were on both. About 71(37.77%) patients were found to be
hypertensive, and 70(36.8%) patients were smokers. The mean duration of diabetic foot was 2.23±1.93 months and the
mean MMSE score was 23.86±2.95. Poor cognitive functioning was found in 99(52.11%) patients.

Conclusion

It is concluded that poor cognitive function in diabetic patients with diabetic foot significantly contributes to
the disease.

Keywords
Poor Cognitive Functioning Diabetic Foot diabetes mellitus

How to Cite This Article

Nadeem H, Khan JA, Umar M, Nadeem MU, Mustafa MB, Asmat F. Assessment of Cognitive Functioning in Diabetic Patients with Diabetic Foot. J Pak Soc Intern Med. 2024;5(4):720–722. doi:10.70302/jpsim.v5i4.2472

⭳ Download PDF

Conflict of Interest

All authors declare no competing interests.

Disclosed in accordance with ICMJE and COPE guidelines.

Funding

No specific funding was received for this research.

Funder information follows the Crossref Funder Registry standard.

References

  1. Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence. New England Journal of Medicine. 2017;376(24):2367-75.
  2. Zhang P, Lu J, Jing Y, Tang S, Zhu D, Bi Y. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Annals of Medicine. 2017;49(2):106-16.
  3. Mishra SC, Chhatbar KC, Kashikar A, Mehndiratta A. Diabetic foot. Bmj. 2017;359:j5064.
  4. Amin N, Doupis J. Diabetic foot disease: From the evaluation of the "foot at risk" to the novel diabetic ulcer treatment modalities. World J Diabetes. 2016;7(7):153-64.
  5. Khan A, Junaid N. Prevalence of diabetic foot syndrome amongst population with type 2 diabetes in Pakistan in primary care settings. Jpma. 2017;67(1818).
  6. J. A. The diabetic foot. Diabetes & Metabolic Syndrome: . Clinical Research & Reviews 01/01/. 2016;10:(01):48-60.
  7. Natovich R, Kushnir T, Harman-Boehm I, Margalit D, Siev-Ner I, Tsalichin D, et al. Cognitive dysfunction: part and parcel of the diabetic foot. Diabetes Care. 2016;39(7):1202-7.
  8. Ryan C, Vega A, Drash A. Cognitive deficits in adolescents who developed diabetes early in life. Pediatrics. 1985;75(5):921-7.
  9. Ryan CM. Diabetes and brain damage: more (or less) than meets the eye? Diabetologia. 2006;49(10):2229-33.
  10. Gamal W, Abbas M, Mohamed A. Study of Cognitive Impairment between Diabetic Foot Patients. J Vasc Med Surg. 2018;6(369):2.
  11. Kanaya AM, Barrett-Connor E, Gildengorin G, Yaffe K. Change in cognitive function by glucose tolerance status in older adults: a 4-year prospective study of the Rancho Bernardo study cohort. Archives of internal medicine. 2004;164(12):1327-33.
  12. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KV, et al. Is diabetes associated with cognitive impairment and cognitive decline among older women? Archives of internal medicine. 2000;160(2):174-80.
  13. Van den Berg E, Reijmer Y, De Bresser J, Kessels R, Kappelle L, Biessels G. A 4 year follow-up study of cognitive functioning in patients with type 2 diabetes mellitus. Diabetologia. 2010;53(1):58-65.
  14. Naguib R, Soliman ES, Neimatallah FM, AlKhudhairy NS, ALGhamdi AM, Almosa RS, et al. Cognitive impairment among patients with diabetes in Saudi Arabia: a cross-sectional study. Middle East Current Psychiatry. 2020;27(1):1-11.
  15. Rawlings AM, Sharrett AR, Schneider AL, Coresh J, Albert M, Couper D, et al. Diabetes in midlife and cognitive change over 20 years: a cohort study. Annals of internal medicine. 2014;161(11):785-93.
  16. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes research and clinical practice. 2011;94(3):311-21.
  17. Alkhunizan M, Alkhenizan A, Basudan L. Prevalence of mild cognitive impairment and dementia in Saudi Arabia: a community-based study. Dementia and Geriatric Cognitive Disorders Extra. 2018;8(1):98-103.
  18. Roy S, Kim N, Desai A, Komaragiri M, Baxi N, Jassil N, et al. Cognitive function and control of type 2 diabetes mellitus in young adults. North American journal of medical sciences. 2015;7(5):220.

Reference list indexed for Google Scholar and ResearchGate. DOI links resolve via doi.org.

CC BY CC BY 4.0 This article is published under the Creative Commons Attribution 4.0 International License. May be shared and adapted with attribution. © 2024 Journal of Pakistan Society of Internal Medicine.